Bourgeon Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bourgeon Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,822	Closed	-$229K	–	122
2025 Q1	$229K	Buy	2,822 +163	+6%	+$14.6K	0.05%	100
2024 Q4	$239K	Sell	2,659 -12	-0.4%	-$1.16K	0.04%	111
2024 Q3	$264K	Buy	2,671 +244	+10%	+$24K	0.05%	95
2024 Q2	$225K	Buy	2,427 +135	+6%	+$12.1K	0.04%	104
2024 Q1	$217K	Buy	2,292 +352	+18%	+$32.7K	0.04%	106
2023 Q4	$173K	Sell	1,940 -2,352	-55%	-$175K	0.04%	106
2023 Q3	$313K	Buy	4,292 +278	+7%	+$22.2K	0.07%	86
2023 Q2	$334K	Sell	4,014 -163	-4%	-$13.6K	0.08%	87
2023 Q1	$318K	Buy	4,177 +2,917	+232%	+$242K	0.08%	82
2022 Q4	$105K	Buy	+1,260	New	+$102K	0.03%	126

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Bourgeon Capital Management's XBI Position: Q2 2025 in Review

Bourgeon Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 2,822 shares — an estimated $229K sold.

Bourgeon Capital Management first reported a position in XBI in Q4 2022 and held it in 10 quarters. The position peaked at $334K in Q2 2023. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Bourgeon Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Bourgeon Capital Management sold 2,822 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $229K.
Bourgeon Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 10 quarters.
Bourgeon Capital Management's State Street SPDR S&P Biotech ETF position peaked at $334K in Q2 2023.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Bourgeon Capital Management's 13F filing for Q2 2025, filed 18 Jul 2025.